Leonard Hayflick
From Ganfyd
(Difference between revisions)
(productive still at 80 odd in a field I have some interest) |
m (categorise) |
||
| Line 7: | Line 7: | ||
{{refsec}} | {{refsec}} | ||
[[Category:People|Hayflick, Leonard]] | [[Category:People|Hayflick, Leonard]] | ||
| + | [[Category:Gerontology]] | ||
Latest revision as of 12:26, 17 January 2009
Web Resources for Leonard Hayflick
Relevant Clinical Literature
UK Guidance
Other Wikis
Medpedia on Leonard Hayflick (Less technical, good quality control)
Wikipedia on Leonard Hayflick (Less technical, ? quality control)
Leonard Hayflick (1928 - ?) is the microbiologist who:
- First isolated Mycoplasma pneumoniae on Hayflick media
- Realised the significance of the Hayflick limit[1] that had been noted by 1961[2]
- Developed the human cell line WI-38 strain used in producing rubella vaccine amongst others (The most widely used and highly characterized normal human cell line which also got him into controversy in 1975 for commercial exploitation of publicly funded research)[3]
- Contributed significantly to gerontology[4].
References
- ↑ HAYFLICK L. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Experimental cell research. 1965 Mar; 37:614-36.
- ↑ HAYFLICK L, MOORHEAD PS. The serial cultivation of human diploid cell strains. Experimental cell research. 1961 Dec; 25:585-621.
- ↑ http://query.nytimes.com/gst/fullpage.html?res=9403E1D81138F93AA25752C0A964948260&sec=&spon=&pagewanted=all Boffey P.M. The fall and rise of Leonard Hayflick... New York Times January 19, 1982 accessed 17 Jan 2009
- ↑ Hayflick L. Entropy explains aging, genetic determinism explains longevity, and undefined terminology explains misunderstanding both. PLoS genetics. 2007 Dec; 3(12):e220.(Link to article – subscription may be required.)
